Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Pharmaceutical composition and a method for treating neurodegenerative diseases using a combination of a kainate excitatory amino acid antagonist and an uricosuric agent

US Patent 5942513 · Granted Aug 24, 1999

Estimated economic value: $235,854,000

Assignee

Inventors

View full patent text on Google Patents →